Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis
Crossref DOI link: https://doi.org/10.1007/s11748-016-0626-3
Published Online: 2016-02-11
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamashita, Keishi
Katada, Natsuya
Moriya, Hiromitsu
Hosoda, Kei
Mieno, Hiroaki
Katada, Chikatoshi
Koizumi, Wasaburo
Hoshi, Keika
Watanabe, Masahiko
Text and Data Mining valid from 2016-02-11